Nebulizers Play a Significant Role in the Treatment during the COVID-19 Pandemic | Arizton

The global nebulizer market size is expected to grow a CAGR of over 7% during the period 2019-2015.
CHICAGO - July 17, 2020 - PRLog -- Arizton's recent market research report states that the global Nebulizer market size is expected to grow at a CAGR of over 7% during the period 2019−2025. The nebulizers play a significant role in the treatment of the COVID-19 pandemic. Among the COVID-19 patients, approximately 15% to 20% of the patients require assisted breathing, as lungs are majorly affected by the virus. This assistance is provided by medical ventilators.  In addition, nebulizers are used with the medicines which loosen the brittle lungs in patients and help them to breathe. This is used to treat critically ill patients across the globe. The demand for home nebulizers is increasing across the developed countries. There is a huge surge in demand for nebulizers and the drugs used to treat asthma and COPD patients. Much of the global community was not prepared financially, technologically, or materially, to implement the measures that have been employed to contain COVID-19 as it was initially restricted to only China.

Key Highlights Offered in the Global Nebulizer Market Research Report:

• The US is the major contributor to the global nebulizers market and is likely to witness an incremental growth rate of around $120 million during the forecast period.
• Mesh nebulizers will have the highest absolute growth of around 72%, due to its enhanced drug delivery with increased safety features.
• The hospital segment dominates the market, however, the home healthcare centers have a faster growth rate, 4 out of 5 hospitals are treating the COVID-19 patients, asthma, COPD patients are diverted to the home healthcare centers for the treatments, hence the demand for the nebulizers in the home healthcare segment has increased.
• The COVID-19 patients are given medications through the nebulizers along with the ventilators, the number of nebulizers used in the emergency units has gone up, this has created the shortage of nebulizers for normal asthma, COPD patients in various countries.
• Vendors across the globe have increased their production of the nebulizers two to three times higher than the normal production to meet the demand for the nebulizers across the globe due to the COVID-19 pandemic.
• Vendors have actively engaged in the development of the new product and commercially launched patient-friendly devices, with enhanced drug transfer featuring the latest mesh nebulizer in recent years.

Request for a free sample!

Posted By:*** Email Verified
Location:Chicago - Illinois - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Arizton Advisory & Intelligence PRs
Trending News
Most Viewed
Top Daily News

Like PRLog?
Click to Share